Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activity of sunitinib in patients with advanced neuroendocrine tumors.
Kulke MH, Lenz HJ, Meropol NJ, Posey J, Ryan DP, Picus J, Bergsland E, Stuart K, Tye L, Huang X, Li JZ, Baum CM, Fuchs CS. Kulke MH, et al. Among authors: li jz. J Clin Oncol. 2008 Jul 10;26(20):3403-10. doi: 10.1200/JCO.2007.15.9020. J Clin Oncol. 2008. PMID: 18612155 Clinical Trial.
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.
Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI. Motzer RJ, et al. Among authors: li jz. J Clin Oncol. 2006 Jan 1;24(1):16-24. doi: 10.1200/JCO.2005.02.2574. Epub 2005 Dec 5. J Clin Oncol. 2006. PMID: 16330672 Clinical Trial.
Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a phase III trial: final results and geographical analysis.
Cella D, Michaelson MD, Bushmakin AG, Cappelleri JC, Charbonneau C, Kim ST, Li JZ, Motzer RJ. Cella D, et al. Among authors: li jz. Br J Cancer. 2010 Feb 16;102(4):658-64. doi: 10.1038/sj.bjc.6605552. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104222 Free PMC article. Clinical Trial.
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients.
Patel SV, Leeman BM, Botros PJ, Folta J, Shahid D, Rocque AI, Joyal AS, Vecchio JA, Passell E, Tien D, Reynolds Z, Su K, Vyas TD, Vyas JM, Abar E, Barry M, Alexandrescu A, Wallace Z, DaCosta JM, Choudhary MC, Tamura T, Edelstein G, Li Y, Deo R, Sparks JA, Boucau J, Glover O, Barczak A, Lemieux J, Siedner MJ, Li JZ, Fofana IB. Patel SV, et al. Among authors: li jz. Res Sq [Preprint]. 2024 Dec 5:rs.3.rs-5487774. doi: 10.21203/rs.3.rs-5487774/v1. Res Sq. 2024. PMID: 39678346 Free PMC article. Preprint.
Viral and Immune Risk Factors of HIV Rebound after Interruption of Antiretroviral Therapy.
Gianella S, Yu T, Wang R, Ignacio C, Schanz M, Kouyos RD, Caballero G, Gaitan N, Rawlings S, Kuster H, Metzner KJ, Gandhi RT, Li JZ, Günthard H, Smith DM, Chaillon A. Gianella S, et al. Among authors: li jz. J Infect Dis. 2024 Dec 11:jiae585. doi: 10.1093/infdis/jiae585. Online ahead of print. J Infect Dis. 2024. PMID: 39661441
1,114 results